MMP-13 selective isonipecotamide α-sulfone hydroxamates
Authors:
- Susan L. HockermanSHSusan L. Hockerman
- Gary A. DeCrescenzoGDGary A. DeCrescenzo
- Joseph J. McDonaldJMJoseph J. McDonald
- Debbie A. MischkeDMDebbie A. Mischke
- Grace E. MunieGMGrace E. Munie
- Theresa R. FletcherTFTheresa R. Fletcher
- Nathan StehleNSNathan Stehle
- Craig SwearingenCSCraig Swearingen
- Daniel P. BeckerDBDaniel P. Becker
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (12) , 3561-3564
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective α-sulfone hydroxamatesBioorganic & Medicinal Chemistry Letters, 2010
- Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13Bioorganic & Medicinal Chemistry Letters, 2007
- Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?Current Opinion in Pharmacology, 2007
- Identification of potent and selective TACE inhibitors via the S1 pocketBioorganic & Medicinal Chemistry Letters, 2007
- Synthesis and SAR of α-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Recent advances in MMP inhibitor designCancer and Metastasis Reviews, 2006
- Identification of potent and selective MMP-13 inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Matrix metalloproteinases: a tail of a frog that became a princeNature Reviews Molecular Cell Biology, 2002
- α-Alkyl-α-amino-β-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1Bioorganic & Medicinal Chemistry Letters, 2001
- α-Amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1Bioorganic & Medicinal Chemistry Letters, 2001